Novel Therapeutic Options in PAH

PROGRAM DESCRIPTION In this video-based interview, Dan Schuller, MD, reviews emerging management and therapeutic models for pulmonary arterial hypertension (PAH) treatment. Dr. Schuller addresses adverse therapeutic events, strategies for complex ...

PROGRAM DESCRIPTION
In this video-based interview, Dan Schuller, MD, reviews emerging management and therapeutic models for pulmonary arterial hypertension (PAH) treatment. Dr. Schuller addresses adverse therapeutic events, strategies for complex PAH cases, and related clinical trial data for both current and emerging PAH therapies. He additionally discusses advanced-practice strategies related to PAH disease classification, risk stratification, and therapeutic selection criteria, especially for complex PAH cases. This is the first in a series of two educational activities on PAH to be released in 2018.

EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants will be able to:Evaluate recent changes and updates to the disease classifications/risk stratifications of PAH and related therapeuticsList emerging clinical research initiatives in PAH and their potential impact on both current and future patient care plans across at-risk populationsEvaluate causes of complex and mixed PH and related referral/treatment strategies

---

Write the first review

Resource tags